Maria Teresa P.
- Country
- Italy
- Department
- Clinica Neurologica
Research Overview
- Phase 2 Randomized, Double-blind, Placebo-controlled Study of Emrusolmin in Adult Patients with Multiple System Atrophy
- Efficacy and Durability of Ampreloxetine in Treating Symptomatic Neurogenic Orthostatic Hypotension in Multiple System Atrophy: A Phase 3 Study
- Phase 2 Open-Label Extension Study to Evaluate the Safety and Efficacy of Emrusolmin in Adults with Multiple System Atrophy
Data & Insights
Has run more than one trial at 22 of 68 partner sites.
Specializations
Neurodegenerative Disorders
The investigator specializes in the treatment and research of Multiple System Atrophy (MSA), a progressive neurodegenerative disorder affecting multiple body systems.
- Disease Progression Management
- Novel Therapeutic Approaches
- Clinical Assessment Methods
Focusing on developing innovative therapeutic strategies for MSA patients through clinical evaluation of emerging treatments.
Autonomic Disorders
Expertise in treating Neurogenic Orthostatic Hypotension (nOH), particularly as it manifests in patients with Multiple System Atrophy.
- Blood Pressure Regulation
- Symptomatic Management
- Treatment Durability Assessment
Investigating long-term therapeutic solutions for autonomic dysfunction in neurological conditions.
Clinical Applications
The investigator evaluates novel therapeutic compounds for treating MSA and related neurological conditions.
- Oral Therapeutic Agents
- Treatment Efficacy Assessment
- Patient Response Monitoring
Dedicated to advancing treatment options through systematic evaluation of new therapeutic interventions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.